Global Antibodies in Oncology Market Growth (Status and Outlook) 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Antibodies in Oncology Market Size 2017-2028

2.1.2 Antibodies in Oncology Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Antibodies in Oncology Segment by Type

2.2.1 Murine Antibodies

2.2.2 Chimeric and Humanised Antibodies

2.2.3 Fully Humanized Antibodies

2.2.4 Others

2.3 Antibodies in Oncology Market Size by Type

2.3.1 Antibodies in Oncology Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Antibodies in Oncology Market Size Market Share by Type (2017-2022)

2.4 Antibodies in Oncology Segment by Application

2.4.1 Hospitals

2.4.2 Academic Institutes

2.4.3 Clinics

2.5 Antibodies in Oncology Market Size by Application

2.5.1 Antibodies in Oncology Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Antibodies in Oncology Market Size Market Share by Application (2017-2022)

3 Antibodies in Oncology Market Size by Player

3.1 Antibodies in Oncology Market Size Market Share by Players

3.1.1 Global Antibodies in Oncology Revenue by Players (2020-2022)

3.1.2 Global Antibodies in Oncology Revenue Market Share by Players (2020-2022)

3.2 Global Antibodies in Oncology Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Antibodies in Oncology by Regions

4.1 Antibodies in Oncology Market Size by Regions (2017-2022)

4.2 Americas Antibodies in Oncology Market Size Growth (2017-2022)

4.3 APAC Antibodies in Oncology Market Size Growth (2017-2022)

4.4 Europe Antibodies in Oncology Market Size Growth (2017-2022)

4.5 Middle East & Africa Antibodies in Oncology Market Size Growth (2017-2022)

5 Americas

5.1 Americas Antibodies in Oncology Market Size by Country (2017-2022)

5.2 Americas Antibodies in Oncology Market Size by Type (2017-2022)

5.3 Americas Antibodies in Oncology Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Antibodies in Oncology Market Size by Region (2017-2022)

6.2 APAC Antibodies in Oncology Market Size by Type (2017-2022)

6.3 APAC Antibodies in Oncology Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Antibodies in Oncology by Country (2017-2022)

7.2 Europe Antibodies in Oncology Market Size by Type (2017-2022)

7.3 Europe Antibodies in Oncology Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Antibodies in Oncology by Region (2017-2022)

8.2 Middle East & Africa Antibodies in Oncology Market Size by Type (2017-2022)

8.3 Middle East & Africa Antibodies in Oncology Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Antibodies in Oncology Market Forecast

10.1 Global Antibodies in Oncology Forecast by Regions (2023-2028)

10.1.1 Global Antibodies in Oncology Forecast by Regions (2023-2028)

10.1.2 Americas Antibodies in Oncology Forecast

10.1.3 APAC Antibodies in Oncology Forecast

10.1.4 Europe Antibodies in Oncology Forecast

10.1.5 Middle East & Africa Antibodies in Oncology Forecast

10.2 Americas Antibodies in Oncology Forecast by Country (2023-2028)

10.2.1 United States Antibodies in Oncology Market Forecast

10.2.2 Canada Antibodies in Oncology Market Forecast

10.2.3 Mexico Antibodies in Oncology Market Forecast

10.2.4 Brazil Antibodies in Oncology Market Forecast

10.3 APAC Antibodies in Oncology Forecast by Region (2023-2028)

10.3.1 China Antibodies in Oncology Market Forecast

10.3.2 Japan Antibodies in Oncology Market Forecast

10.3.3 Korea Antibodies in Oncology Market Forecast

10.3.4 Southeast Asia Antibodies in Oncology Market Forecast

10.3.5 India Antibodies in Oncology Market Forecast

10.3.6 Australia Antibodies in Oncology Market Forecast

10.4 Europe Antibodies in Oncology Forecast by Country (2023-2028)

10.4.1 Germany Antibodies in Oncology Market Forecast

10.4.2 France Antibodies in Oncology Market Forecast

10.4.3 UK Antibodies in Oncology Market Forecast

10.4.4 Italy Antibodies in Oncology Market Forecast

10.4.5 Russia Antibodies in Oncology Market Forecast

10.5 Middle East & Africa Antibodies in Oncology Forecast by Region (2023-2028)

10.5.1 Egypt Antibodies in Oncology Market Forecast

10.5.2 South Africa Antibodies in Oncology Market Forecast

10.5.3 Israel Antibodies in Oncology Market Forecast

10.5.4 Turkey Antibodies in Oncology Market Forecast

10.5.5 GCC Countries Antibodies in Oncology Market Forecast

10.6 Global Antibodies in Oncology Forecast by Type (2023-2028)

10.7 Global Antibodies in Oncology Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Novartis International AG

11.1.1 Novartis International AG Company Information

11.1.2 Novartis International AG Antibodies in Oncology Product Offered

11.1.3 Novartis International AG Antibodies in Oncology Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Novartis International AG Main Business Overview

11.1.5 Novartis International AG Latest Developments

11.2 GlaxoSmithKline plc

11.2.1 GlaxoSmithKline plc Company Information

11.2.2 GlaxoSmithKline plc Antibodies in Oncology Product Offered

11.2.3 GlaxoSmithKline plc Antibodies in Oncology Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 GlaxoSmithKline plc Main Business Overview

11.2.5 GlaxoSmithKline plc Latest Developments

11.3 Biogen Idec Inc.

11.3.1 Biogen Idec Inc. Company Information

11.3.2 Biogen Idec Inc. Antibodies in Oncology Product Offered

11.3.3 Biogen Idec Inc. Antibodies in Oncology Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Biogen Idec Inc. Main Business Overview

11.3.5 Biogen Idec Inc. Latest Developments

11.4 Bristol Myers Squibb Co.

11.4.1 Bristol Myers Squibb Co. Company Information

11.4.2 Bristol Myers Squibb Co. Antibodies in Oncology Product Offered

11.4.3 Bristol Myers Squibb Co. Antibodies in Oncology Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Bristol Myers Squibb Co. Main Business Overview

11.4.5 Bristol Myers Squibb Co. Latest Developments

11.5 AstraZeneca plc.

11.5.1 AstraZeneca plc. Company Information

11.5.2 AstraZeneca plc. Antibodies in Oncology Product Offered

11.5.3 AstraZeneca plc. Antibodies in Oncology Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 AstraZeneca plc. Main Business Overview

11.5.5 AstraZeneca plc. Latest Developments

11.6 Celltrion

11.6.1 Celltrion Company Information

11.6.2 Celltrion Antibodies in Oncology Product Offered

11.6.3 Celltrion Antibodies in Oncology Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 Celltrion Main Business Overview

11.6.5 Celltrion Latest Developments

11.7 3SBIO

11.7.1 3SBIO Company Information

11.7.2 3SBIO Antibodies in Oncology Product Offered

11.7.3 3SBIO Antibodies in Oncology Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 3SBIO Main Business Overview

11.7.5 3SBIO Latest Developments

11.8 Celgen Biopharma

11.8.1 Celgen Biopharma Company Information

11.8.2 Celgen Biopharma Antibodies in Oncology Product Offered

11.8.3 Celgen Biopharma Antibodies in Oncology Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Celgen Biopharma Main Business Overview

11.8.5 Celgen Biopharma Latest Developments

11.9 Dr Reddy’s

11.9.1 Dr Reddy’s Company Information

11.9.2 Dr Reddy’s Antibodies in Oncology Product Offered

11.9.3 Dr Reddy’s Antibodies in Oncology Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 Dr Reddy’s Main Business Overview

11.9.5 Dr Reddy’s Latest Developments

12 Research Findings and Conclusion

Table 1. Antibodies in Oncology Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Murine Antibodies

Table 3. Major Players of Chimeric and Humanised Antibodies

Table 4. Major Players of Fully Humanized Antibodies

Table 5. Major Players of Others

Table 6. Antibodies in Oncology Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 7. Global Antibodies in Oncology Market Size by Type (2017-2022) & ($ Millions)

Table 8. Global Antibodies in Oncology Market Size Market Share by Type (2017-2022)

Table 9. Antibodies in Oncology Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 10. Global Antibodies in Oncology Market Size by Application (2017-2022) & ($ Millions)

Table 11. Global Antibodies in Oncology Market Size Market Share by Application (2017-2022)

Table 12. Global Antibodies in Oncology Revenue by Players (2020-2022) & ($ Millions)

Table 13. Global Antibodies in Oncology Revenue Market Share by Player (2020-2022)

Table 14. Antibodies in Oncology Key Players Head office and Products Offered

Table 15. Antibodies in Oncology Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 16. New Products and Potential Entrants

Table 17. Mergers & Acquisitions, Expansion

Table 18. Global Antibodies in Oncology Market Size by Regions 2017-2022 & ($ Millions)

Table 19. Global Antibodies in Oncology Market Size Market Share by Regions (2017-2022)

Table 20. Americas Antibodies in Oncology Market Size by Country (2017-2022) & ($ Millions)

Table 21. Americas Antibodies in Oncology Market Size Market Share by Country (2017-2022)

Table 22. Americas Antibodies in Oncology Market Size by Type (2017-2022) & ($ Millions)

Table 23. Americas Antibodies in Oncology Market Size Market Share by Type (2017-2022)

Table 24. Americas Antibodies in Oncology Market Size by Application (2017-2022) & ($ Millions)

Table 25. Americas Antibodies in Oncology Market Size Market Share by Application (2017-2022)

Table 26. APAC Antibodies in Oncology Market Size by Region (2017-2022) & ($ Millions)

Table 27. APAC Antibodies in Oncology Market Size Market Share by Region (2017-2022)

Table 28. APAC Antibodies in Oncology Market Size by Type (2017-2022) & ($ Millions)

Table 29. APAC Antibodies in Oncology Market Size Market Share by Type (2017-2022)

Table 30. APAC Antibodies in Oncology Market Size by Application (2017-2022) & ($ Millions)

Table 31. APAC Antibodies in Oncology Market Size Market Share by Application (2017-2022)

Table 32. Europe Antibodies in Oncology Market Size by Country (2017-2022) & ($ Millions)

Table 33. Europe Antibodies in Oncology Market Size Market Share by Country (2017-2022)

Table 34. Europe Antibodies in Oncology Market Size by Type (2017-2022) & ($ Millions)

Table 35. Europe Antibodies in Oncology Market Size Market Share by Type (2017-2022)

Table 36. Europe Antibodies in Oncology Market Size by Application (2017-2022) & ($ Millions)

Table 37. Europe Antibodies in Oncology Market Size Market Share by Application (2017-2022)

Table 38. Middle East & Africa Antibodies in Oncology Market Size by Region (2017-2022) & ($ Millions)

Table 39. Middle East & Africa Antibodies in Oncology Market Size Market Share by Region (2017-2022)

Table 40. Middle East & Africa Antibodies in Oncology Market Size by Type (2017-2022) & ($ Millions)

Table 41. Middle East & Africa Antibodies in Oncology Market Size Market Share by Type (2017-2022)

Table 42. Middle East & Africa Antibodies in Oncology Market Size by Application (2017-2022) & ($ Millions)

Table 43. Middle East & Africa Antibodies in Oncology Market Size Market Share by Application (2017-2022)

Table 44. Key Market Drivers & Growth Opportunities of Antibodies in Oncology

Table 45. Key Market Challenges & Risks of Antibodies in Oncology

Table 46. Key Industry Trends of Antibodies in Oncology

Table 47. Global Antibodies in Oncology Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 48. Global Antibodies in Oncology Market Size Market Share Forecast by Regions (2023-2028)

Table 49. Global Antibodies in Oncology Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 50. Global Antibodies in Oncology Market Size Market Share Forecast by Type (2023-2028)

Table 51. Global Antibodies in Oncology Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 52. Global Antibodies in Oncology Market Size Market Share Forecast by Application (2023-2028)

Table 53. Novartis International AG Details, Company Type, Antibodies in Oncology Area Served and Its Competitors

Table 54. Novartis International AG Antibodies in Oncology Product Offered

Table 55. Novartis International AG Antibodies in Oncology Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 56. Novartis International AG Main Business

Table 57. Novartis International AG Latest Developments

Table 58. GlaxoSmithKline plc Details, Company Type, Antibodies in Oncology Area Served and Its Competitors

Table 59. GlaxoSmithKline plc Antibodies in Oncology Product Offered

Table 60. GlaxoSmithKline plc Main Business

Table 61. GlaxoSmithKline plc Antibodies in Oncology Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 62. GlaxoSmithKline plc Latest Developments

Table 63. Biogen Idec Inc. Details, Company Type, Antibodies in Oncology Area Served and Its Competitors

Table 64. Biogen Idec Inc. Antibodies in Oncology Product Offered

Table 65. Biogen Idec Inc. Main Business

Table 66. Biogen Idec Inc. Antibodies in Oncology Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 67. Biogen Idec Inc. Latest Developments

Table 68. Bristol Myers Squibb Co. Details, Company Type, Antibodies in Oncology Area Served and Its Competitors

Table 69. Bristol Myers Squibb Co. Antibodies in Oncology Product Offered

Table 70. Bristol Myers Squibb Co. Main Business

Table 71. Bristol Myers Squibb Co. Antibodies in Oncology Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 72. Bristol Myers Squibb Co. Latest Developments

Table 73. AstraZeneca plc. Details, Company Type, Antibodies in Oncology Area Served and Its Competitors

Table 74. AstraZeneca plc. Antibodies in Oncology Product Offered

Table 75. AstraZeneca plc. Main Business

Table 76. AstraZeneca plc. Antibodies in Oncology Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 77. AstraZeneca plc. Latest Developments

Table 78. Celltrion Details, Company Type, Antibodies in Oncology Area Served and Its Competitors

Table 79. Celltrion Antibodies in Oncology Product Offered

Table 80. Celltrion Main Business

Table 81. Celltrion Antibodies in Oncology Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 82. Celltrion Latest Developments

Table 83. 3SBIO Details, Company Type, Antibodies in Oncology Area Served and Its Competitors

Table 84. 3SBIO Antibodies in Oncology Product Offered

Table 85. 3SBIO Main Business

Table 86. 3SBIO Antibodies in Oncology Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 87. 3SBIO Latest Developments

Table 88. Celgen Biopharma Details, Company Type, Antibodies in Oncology Area Served and Its Competitors

Table 89. Celgen Biopharma Antibodies in Oncology Product Offered

Table 90. Celgen Biopharma Main Business

Table 91. Celgen Biopharma Antibodies in Oncology Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 92. Celgen Biopharma Latest Developments

Table 93. Dr Reddy’s Details, Company Type, Antibodies in Oncology Area Served and Its Competitors

Table 94. Dr Reddy’s Antibodies in Oncology Product Offered

Table 95. Dr Reddy’s Main Business

Table 96. Dr Reddy’s Antibodies in Oncology Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 97. Dr Reddy’s Latest Developments

List of Figures

Figure 1. Antibodies in Oncology Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Antibodies in Oncology Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Antibodies in Oncology Market Size Market Share by Type in 2021

Figure 7. Antibodies in Oncology in Hospitals

Figure 8. Global Antibodies in Oncology Market: Hospitals (2017-2022) & ($ Millions)

Figure 9. Antibodies in Oncology in Academic Institutes

Figure 10. Global Antibodies in Oncology Market: Academic Institutes (2017-2022) & ($ Millions)

Figure 11. Antibodies in Oncology in Clinics

Figure 12. Global Antibodies in Oncology Market: Clinics (2017-2022) & ($ Millions)

Figure 13. Global Antibodies in Oncology Market Size Market Share by Application in 2021

Figure 14. Global Antibodies in Oncology Revenue Market Share by Player in 2021

Figure 15. Global Antibodies in Oncology Market Size Market Share by Regions (2017-2022)

Figure 16. Americas Antibodies in Oncology Market Size 2017-2022 ($ Millions)

Figure 17. APAC Antibodies in Oncology Market Size 2017-2022 ($ Millions)

Figure 18. Europe Antibodies in Oncology Market Size 2017-2022 ($ Millions)

Figure 19. Middle East & Africa Antibodies in Oncology Market Size 2017-2022 ($ Millions)

Figure 20. Americas Antibodies in Oncology Value Market Share by Country in 2021

Figure 21. Americas Antibodies in Oncology Consumption Market Share by Type in 2021

Figure 22. Americas Antibodies in Oncology Market Size Market Share by Application in 2021

Figure 23. United States Antibodies in Oncology Market Size Growth 2017-2022 ($ Millions)

Figure 24. Canada Antibodies in Oncology Market Size Growth 2017-2022 ($ Millions)

Figure 25. Mexico Antibodies in Oncology Market Size Growth 2017-2022 ($ Millions)

Figure 26. Brazil Antibodies in Oncology Market Size Growth 2017-2022 ($ Millions)

Figure 27. APAC Antibodies in Oncology Market Size Market Share by Region in 2021

Figure 28. APAC Antibodies in Oncology Market Size Market Share by Application in 2021

Figure 29. China Antibodies in Oncology Market Size Growth 2017-2022 ($ Millions)

Figure 30. Japan Antibodies in Oncology Market Size Growth 2017-2022 ($ Millions)

Figure 31. Korea Antibodies in Oncology Market Size Growth 2017-2022 ($ Millions)

Figure 32. Southeast Asia Antibodies in Oncology Market Size Growth 2017-2022 ($ Millions)

Figure 33. India Antibodies in Oncology Market Size Growth 2017-2022 ($ Millions)

Figure 34. Australia Antibodies in Oncology Market Size Growth 2017-2022 ($ Millions)

Figure 35. Europe Antibodies in Oncology Market Size Market Share by Country in 2021

Figure 36. Europe Antibodies in Oncology Market Size Market Share by Type in 2021

Figure 37. Europe Antibodies in Oncology Market Size Market Share by Application in 2021

Figure 38. Germany Antibodies in Oncology Market Size Growth 2017-2022 ($ Millions)

Figure 39. France Antibodies in Oncology Market Size Growth 2017-2022 ($ Millions)

Figure 40. UK Antibodies in Oncology Market Size Growth 2017-2022 ($ Millions)

Figure 41. Italy Antibodies in Oncology Market Size Growth 2017-2022 ($ Millions)

Figure 42. Russia Antibodies in Oncology Market Size Growth 2017-2022 ($ Millions)

Figure 43. Middle East & Africa Antibodies in Oncology Market Size Market Share by Region in 2021

Figure 44. Middle East & Africa Antibodies in Oncology Market Size Market Share by Type in 2021

Figure 45. Middle East & Africa Antibodies in Oncology Market Size Market Share by Application in 2021

Figure 46. Egypt Antibodies in Oncology Market Size Growth 2017-2022 ($ Millions)

Figure 47. South Africa Antibodies in Oncology Market Size Growth 2017-2022 ($ Millions)

Figure 48. Israel Antibodies in Oncology Market Size Growth 2017-2022 ($ Millions)

Figure 49. Turkey Antibodies in Oncology Market Size Growth 2017-2022 ($ Millions)

Figure 50. GCC Country Antibodies in Oncology Market Size Growth 2017-2022 ($ Millions)

Figure 51. Americas Antibodies in Oncology Market Size 2023-2028 ($ Millions)

Figure 52. APAC Antibodies in Oncology Market Size 2023-2028 ($ Millions)

Figure 53. Europe Antibodies in Oncology Market Size 2023-2028 ($ Millions)

Figure 54. Middle East & Africa Antibodies in Oncology Market Size 2023-2028 ($ Millions)

Figure 55. United States Antibodies in Oncology Market Size 2023-2028 ($ Millions)

Figure 56. Canada Antibodies in Oncology Market Size 2023-2028 ($ Millions)

Figure 57. Mexico Antibodies in Oncology Market Size 2023-2028 ($ Millions)

Figure 58. Brazil Antibodies in Oncology Market Size 2023-2028 ($ Millions)

Figure 59. China Antibodies in Oncology Market Size 2023-2028 ($ Millions)

Figure 60. Japan Antibodies in Oncology Market Size 2023-2028 ($ Millions)

Figure 61. Korea Antibodies in Oncology Market Size 2023-2028 ($ Millions)

Figure 62. Southeast Asia Antibodies in Oncology Market Size 2023-2028 ($ Millions)

Figure 63. India Antibodies in Oncology Market Size 2023-2028 ($ Millions)

Figure 64. Australia Antibodies in Oncology Market Size 2023-2028 ($ Millions)

Figure 65. Germany Antibodies in Oncology Market Size 2023-2028 ($ Millions)

Figure 66. France Antibodies in Oncology Market Size 2023-2028 ($ Millions)

Figure 67. UK Antibodies in Oncology Market Size 2023-2028 ($ Millions)

Figure 68. Italy Antibodies in Oncology Market Size 2023-2028 ($ Millions)

Figure 69. Russia Antibodies in Oncology Market Size 2023-2028 ($ Millions)

Figure 70. Spain Antibodies in Oncology Market Size 2023-2028 ($ Millions)

Figure 71. Egypt Antibodies in Oncology Market Size 2023-2028 ($ Millions)

Figure 72. South Africa Antibodies in Oncology Market Size 2023-2028 ($ Millions)

Figure 73. Israel Antibodies in Oncology Market Size 2023-2028 ($ Millions)

Figure 74. Turkey Antibodies in Oncology Market Size 2023-2028 ($ Millions)

Figure 75. GCC Countries Antibodies in Oncology Market Size 2023-2028 ($ Millions)